广发纳斯达克生物科技C人民币(016470)
动态评分： 5.71分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2023-03-31 | ALNY | Alnylam Pharmaceuticals Inc | 339.73 | 2.25% |
| 2022-12-31 | GILD | 吉利德科学 | 1286.94 | 7.16% |
| 2022-12-31 | AMGN | 安进 | 1212.75 | 6.75% |
| 2022-12-31 | REGN | 再生元制药 | 1177.83 | 6.55% |
| 2022-12-31 | VRTX | 福泰制药 | 1128.3 | 6.28% |
| 2022-12-31 | MRNA | Moderna Inc | 1078.6 | 6% |
| 2022-12-31 | AZN | 阿斯利康(US ADR) | 626.8 | 3.49% |
| 2022-12-31 | BIIB | 生化基因 | 600.58 | 3.34% |
| 2022-12-31 | ILMN | Illumina Inc | 490.35 | 2.73% |
| 2022-12-31 | ALNY | Alnylam Pharmaceuticals Inc | 446.89 | 2.49% |
| 2022-12-31 | HZNP | Horizon Therapeutics plc | 388.36 | 2.16% |
| 2022-12-31 | SGEN | Seagen Inc | 366.78 | 2.04% |
| 2022-12-31 | BMRN | 拜玛林制药 | 292.56 | 1.63% |
| 2022-12-31 | INCY | 因塞特医疗 | 270.8 | 1.51% |
| 2022-12-31 | RPRX | Royalty Pharma plc-A | 264.18 | 1.47% |
| 2022-12-31 | BNTX | BioNTech SE ADR | 215.1 | 1.2% |
| 2022-12-31 | SNY | 赛诺菲 | 211.92 | 1.18% |
| 2022-12-31 | VTRS | Viatris Inc | 205.05 | 1.14% |
| 2022-12-31 | UTHR | 联合治疗 | 192.71 | 1.07% |
| 2022-12-31 | ARGX | argenx SE ADR | 180.2 | 1% |
公告&资料
